Phase 1 pharmacokinetic (PK) study of CT-2103 given Q2 or Q3 weeks in patients with solid tumors

  1. Lookup NU author(s)
  2. Dr Mark Verrill
  3. Professor Alan Boddy
  4. Julieann Sludden
  5. Kevin Fishwick
  6. Lynsey Robson
  7. Dr Jane Cassidy
  8. Professor Alan Calvert
Author(s)Verrill MW, Boddy AV, Todd R, Sludden J, Fishwick KA, Robson L, Cassidy J, Bissett D, Calvert AH
Editor(s)
Publication type Conference Proceedings (inc. Abstract)
Conference NameProceedings of the 39th Annual Meeting of The Americal Society of Clinical Oncology
Conference LocationChicago, Illinois, USA
Year of Conference2003
Legacy Date31-05-2003 - 03-06-2003
Volume22
PagesA 533
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherAmerican Society of Clinical Oncology
URLhttp://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=23&abstractID=104018